Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03095781
Title Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Emory University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Emory University Hospital Midtown Atlanta Georgia 30308 United States Details
Emory University/Winship Cancer Institute Atlanta Georgia 30322 United States Details
Emory Saint Joseph's Hospital Atlanta Georgia 30342 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field